Table 5 Epigenetic biomarkers in the clinical setting
From: Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Epigenetic biomarkers | Related epigenetic regulation | Disease | Reference |
|---|---|---|---|
PHOSPHO1 | DNA methylation | T2D | |
ABCG1 | DNA methylation | T2D | |
TXNIP, SREBF1, and SOCS3 | DNA methylation | T2D | |
cg09822959, cg19686543 | DNA methylation | NAFLD | |
MT-ND6 | DNA methylation | NAFLD | |
ADRB3 | DNA methylation | obesity | |
ZNF267, ABLIM2 | DNA methylation | osteoporosis | |
miR-21-5p, miR-29a-3p, let-7b-5p, and let-7c-5p | miRNA | ESRD in patients with T1D | |
miR-155 | miRNA | T1D | |
miR-21 | miRNA | IGT and prediabetic status | |
miR-3659 | miRNA | Dyslipidaemia and obesity | |
miR‑135a‑3p | miRNA | NAFLD | |
miR-33a | miRNA | NAFLD | |
miR-148a and miR-122-5p | miRNA | osteoporosis | |
hsa_circ_0076690 | circRNA | osteoporosis |
